Larisa Labzin
Dr Labzin studies how macrophages sense and respond to acute viral infections, especially influenza and SARS-CoV-2. Dr Labzin completed her undergraduate studies at UQ including her honours studies at the IMB with Prof. Matt Sweet and Prof. Kate Schroder, investigating how macrophage inflammatory responses are regulated by histone deacetylases. Dr Labzin’s PhD research at the University of Bonn, Germany (awarded 2015), with Prof. Eicke Latz, uncovered how High Density Lipoprotein, aka, the ‘good cholesterol’ is anti-inflammatory through the transcriptional repressor ATF3. During this time Dr Labzin also uncovered how ATF3 regulates anti-viral signalling pathways. Dr Labzin moved to the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK for her postdoctoral research with Dr Leo James. Here she discovered how antibodies change how innate immune cells sense viral infections, and this sparked her ongoing fascination with how viruses trigger inflammation. In 2019, Dr Labzin returned to the IMB to work with Prof. Kate Schroder and to continue investigating how inflammation is sparked during viral infections.
Abstracts this author is presenting: